• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 5. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088

Introduction to 4-Bromoisoquinolin-5-amine (CAS No. 16552-65-1)

4-Bromoisoquinolin-5-amine, with the chemical formula C?H?BrN?, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the isoquinoline family, a class of nitrogen-containing aromatic organic compounds known for their diverse biological activities. The presence of both bromine and amine functional groups in its structure makes it a versatile intermediate for synthesizing various pharmacologically active molecules.

The CAS No. 16552-65-1 identifier ensures its unique distinction in chemical databases and literature, facilitating accurate referencing and research continuity. As a key intermediate, 4-Bromoisoquinolin-5-amine plays a pivotal role in the development of novel therapeutic agents targeting various diseases, including cancer, infectious disorders, and neurological conditions.

In recent years, the pharmaceutical industry has witnessed a surge in the exploration of isoquinoline derivatives due to their promising biological properties. The bromine atom in 4-Bromoisoquinolin-5-amine enhances its reactivity, making it an attractive scaffold for further chemical modifications. This reactivity has been exploited in the synthesis of small-molecule inhibitors that modulate critical biological pathways involved in disease progression.

One of the most compelling aspects of 4-Bromoisoquinolin-5-amine is its utility in drug discovery programs aimed at addressing unmet medical needs. Researchers have leveraged its structural framework to develop compounds with enhanced binding affinity and selectivity towards specific biological targets. For instance, studies have demonstrated its potential in generating inhibitors of kinases and other enzymes implicated in cancer metabolism.

The amine group in 4-Bromoisoquinolin-5-amine serves as a versatile handle for further functionalization, allowing chemists to introduce additional pharmacophores or modify existing ones. This flexibility has enabled the creation of libraries of derivatives with tailored biological activities. High-throughput screening (HTS) campaigns have identified several promising candidates derived from 4-Bromoisoquinolin-5-amine, which are now undergoing further optimization.

Advances in computational chemistry and molecular modeling have further accelerated the design of novel analogs based on 4-Bromoisoquinolin-5-amine. These computational tools enable researchers to predict the binding modes of potential drug candidates with high precision, thereby reducing the time and cost associated with experimental screening. Such integrative approaches have been instrumental in streamlining drug development pipelines.

Recent publications highlight the role of 4-Bromoisoquinolin-5-amine in developing antiviral agents. The isoquinoline core has been shown to interact with viral proteases and polymerases, inhibiting their activity and thereby halting viral replication. The bromine substituent enhances these interactions by improving solubility and metabolic stability, making it an ideal candidate for further derivatization.

The synthesis of 4-Bromoisoquinolin-5-amine itself is a testament to the ingenuity of organic chemists. Traditional methods involve multi-step reactions starting from readily available precursors such as isoquinoline or its derivatives. Modern synthetic strategies have improved yields and purity, ensuring that researchers have access to high-quality starting materials for their investigations.

The growing interest in 4-Bromoisoquinolin-5-amine has also spurred innovation in green chemistry principles. Researchers are exploring sustainable synthetic routes that minimize waste and reduce environmental impact. These efforts align with global initiatives to promote sustainable pharmaceutical manufacturing practices.

In conclusion, 4-Bromoisoquinolin-5-amine (CAS No. 16552-65-1) represents a cornerstone compound in medicinal chemistry due to its structural versatility and biological relevance. Its continued investigation promises to yield novel therapeutic agents that address some of the most pressing health challenges faced by humanity today.

• 65340-75-2(4-Amino-8-bromoquinoline)
• 7101-96-4(3-Bromoquinolin-6-amine)
• 116632-58-7(8-Bromoquinolin-5-amine)
• 90721-35-0(5-Bromoisoquinolin-8-amine)
• 566943-98-4(5-Bromo-6-isoquinolinamine)
• 351458-46-3(4-bromoisoquinolin-8-amine)
• 525590-24-3(3-Bromo-1H-indol-5-amine)
• 13535-01-8(5-bromopyridin-3-amine)
• 196205-07-9(7-Bromo-1H-indol-5-amine)
• 90721-34-9(8-Bromoisoquinolin-5-amine)